Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Impact of Pilates Exercises Added to Pelvic Floor Muscle Training and Sildenafil on Diabetic Erectile Dysfunction. (PilatesDED2025)

13. november 2026 opdateret af: Mahmoud Hamada Mohamed, Benha University

Pilates Exercises Added to Pelvic Floor Muscle Training and Sildenafil for Diabetic Erectile Dysfunction: A Randomized Controlled Trial

Erectile dysfunction (ED) has a prevalence of 52.5% in diabetic male patients, as described in a meta-analysis of 145 studies, including 88,577 men with type 1 and type 2 diabetes.

In men, ED can cause sexual dissatisfaction and distress, unsatisfactory relationships, and marital tension

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Pilates emerged as a method of rehabilitation during World War I, when Joseph Hubertus Pilates applied his knowledge to rehabilitate injured men. The popularity of the method grew most in the 1980. More recently, Pilates has been used resulting in improved fitness (flexibility, strength and balance) and body consciousness. The method features ground-based exercises created by Joseph Pilates.

Because most Pilates exercises are performed in conjunction with the recruitment of PF muscle fibres, many Pilates instructors believe that the method can produce a significant increase in the force or contractility of the muscles. Furthermore, if Pilates promotes an improvement in the functioning of the pelvic floor muscles (PFM), it may be an alternative for the treatment and prevention of pelvic floor dysfunction.

Up till now, no published trials about impact of Pilate exercises on diabetic erectile dysfunction.

A total of 60 patients (n=30 per group), diagnosed with diabetic erectile dysfunction in the past 6 months. Participants will be recruited from Benha University hospital and local andrology and urology clinics in benha and giza . Participants will be screened for eligibility prior to being enrolled in the study participating in the study assessments.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

60

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Benha
      • Banhā, Benha, Egypten
        • Outpatient clinic, faculty of Physical Therapy, Benha university

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

40 år til 60 år (Voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Han

Beskrivelse

Inclusion Criteria:

  • Men aged 40-60 years.
  • Married.
  • Diagnosed with type 2 diabetes mellitus for >5 years, with initial diagnosis confirmed by HbA1c >6.5%.
  • Arteriogenic erectile dysfunction (ED) of >6 months' duration, diagnosed using the International Index of Erectile Function-5 (IIEF-5),confirmed by penile Doppler ultrasonography showing peak systolic velocity (PSV) of the cavernosal arteries <25 cm/s.
  • Body mass index (BMI) <30 kg/m².

Exclusion Criteria:

  • Poorly controlled diabetes mellitus (HbA1c >9%).
  • Neurogenic, venogenic, or psychogenic ED.
  • Cardiac conditions contraindicating sexual activity.
  • Neurological disorders or spinal cord injury.
  • Alcohol abuse or illicit drug use.
  • Chronic hematological disorders.
  • Active genitourinary infection.
  • Severe hypogonadism.
  • History of radical prostatectomy, pelvic surgery, or pelvic trauma.
  • Penile prosthesis implantation.
  • Current or previous participation in a structured pelvic floor muscle training or sexual rehabilitation program.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Eksperimentel

The program had 11 mat exercises: Pilates breathing, spine stretch, swan, shoulder bridge, hundreds, double leg stretch, footwork, roll up, single leg stretch, leg pull back, and kick front and back, It had three phases of four weeks each. In the beginner phase (weeks 1 to 4), participants did one set of six to eight repetitions of each exercise, using supported positions and modified movements to establish breathing coordination and lumbopelvic control. In the intermediate phase (weeks 5 to 8), they did two sets of eight to 10 repetitions with larger movement amplitude, longer lever arms, and more challenging limb movements. In the advanced phase (weeks 9 to 12), they did two sets of 10 to 12 repetitions of more complex variations with greater stabilization demands, provided they kept adequate movement control.

Participants attended an educational session conducted by a physiotherapist covering pelvic floor anatomy, the physiology of erection, and the roles of the ischiocavernosus and bulbocavernosus muscles in erectile function. They were instructed on proper pelvic floor muscle contraction using simulated interruption of urine flow and maximal voluntary contractions. A home-based PFMT program was prescribed, initially performed in the supine position with knees flexed and subsequently progressed to sitting or standing positions as tolerated. Participants were instructed to perform PFMT twice daily (morning and evening), consisting of 15 short contractions (1 second each) and 15 sustained contractions (6-10 seconds each). Adherence was monitored through a mobile messaging application, via which participants reported completion of their daily exercises and received reminders when necessary.

Participants received sildenafil citrate 25 mg orally once daily and sildenafil citrate 50 mg orally on demand, taken approximately 1 hour before sexual intercourse, throughout the study period.

Aktiv komparator: Aktiv komparator

Participants attended an educational session conducted by a physiotherapist covering pelvic floor anatomy, the physiology of erection, and the roles of the ischiocavernosus and bulbocavernosus muscles in erectile function. They were instructed on proper pelvic floor muscle contraction using simulated interruption of urine flow and maximal voluntary contractions. A home-based PFMT program was prescribed, initially performed in the supine position with knees flexed and subsequently progressed to sitting or standing positions as tolerated. Participants were instructed to perform PFMT twice daily (morning and evening), consisting of 15 short contractions (1 second each) and 15 sustained contractions (6-10 seconds each). Adherence was monitored through a mobile messaging application, via which participants reported completion of their daily exercises and received reminders when necessary.

Participants received sildenafil citrate 25 mg orally once daily and sildenafil citrate 50 mg orally on demand, taken approximately 1 hour before sexual intercourse, throughout the study period.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
International Index of Erectile Function-5 (IIEF-5) scale.
Tidsramme: Baseline and after 12 weeks

The IIEF-5 scale is used to assess patients with erectile dysfunction to determine the extent of the erectile function in patients. The full-scale 15-item version has five domains: erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall sexual satisfaction.

The shortened 5-item version is on a scale of 5 to 25:

22-25: No erectile dysfunction 17-21: Mild erectile dysfunction 12-16: Mild to moderate erectile dysfunction 8-11: Moderate erectile dysfunction 5-7: Severe erectile dysfunction

Baseline and after 12 weeks

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
penile perfusion
Tidsramme: Base line and after 12 weeks

Colour-coded duplex sonography (5-10 MHz probes) will be used for the evaluation of penile perfusion. Half ml of a vasoactive agent (trimix solution) will be injected into the corpus cavernosum. The systolic and diastolic velocities (cm/s) will be performed at 10 and 30 min for both cavernous artery. Re-dosing with 0.5 ml of trimax solution will be performed for patients who did not achieve adequate hardness. The highest values obtained will be recorded. The Doppler indices of the right and left cavernous arteries: peak systolic velocity (PSV)

Base line and after 12 weeks

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

15. december 2025

Primær færdiggørelse (Faktiske)

22. juni 2026

Studieafslutning (Faktiske)

11. november 2026

Datoer for studieregistrering

Først indsendt

8. december 2025

Først indsendt, der opfyldte QC-kriterier

8. december 2025

Først opslået (Faktiske)

19. december 2025

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

18. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

13. november 2026

Sidst verificeret

1. december 2025

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • Pilate Exercises for DED2025

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .